Enrofloxacin
-
Catalog numberB2101-500
-
PricePlease ask
-
Size500 mg
-
-
Alternative_name1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid; PD 160788; BAY Vp-2674
-
DescriptionEnrofloxacin is a broad-spectrum fluoroquinolone antibiotic that inhibits bacterial DNA gyrase. Enrofloxacin displays high bioavailability in most species and rapid absorption after oral, intramuscular, or subcutaneous administration. Enrofloxacin demonstrates significant post-antibiotic effect for both Gram-negative and Gram-positive bacteria and is active in both stationary and growth phases of bacterial replication.
-
CAS Number93106-60-6
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₁₉H₂₂FN₃O₃
-
Molecular Weight359.4
-
Cell PermeableYes
-
Purity≥98%
-
SolubilitiesDMSO (1 mg/ml)
-
HandlingProtect from air and light
-
Tag LineA broad-spectrum fluoroquinolone antibiotic
-
Storage Condition-20°C
-
Shipping Conditiongel pack
-
Shelf Life36 months
-
MDL NumberMFCD00792463
-
PubChem CID71188
-
SMILESCCN1CCN(CC1)C2=C(C=C3C(=C2)N(C=C(C3=O)C(=O)O)C4CC4)F
-
InChiInChI=1S/C19H22FN3O3/c1-2-21-5-7-22(8-6-21)17-10-16-13(9-15(17)20)18(24)14(19(25)26)11-23(16)12-3-4-12/h9-12H,2-8H2,1H3,(H,25,26)
-
InChi KeySPFYMRJSYKOXGV-UHFFFAOYSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameEnrofloxacin
-
Alternative nameEnrofloxacin
-
MeSH Data
-
Name
-
ConceptScope note: The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells.
-
Tree numbers
- E05.393.220
-
Qualifiersdrug effects, methods, radiation effects